BOTOX® Cosmetic and DAXXIFY®
BOTOX® Cosmetic (onabotulinumtoxinA)
BOTOX® Cosmetic is an injected prescription medication that temporarily improves the appearance of moderate to severe frown lines between the eyebrows (glabellar lines), crow’s feet (lateral canthus), and forehead. Approximately 11.8 million BOTOX® Cosmetic procedures have been performed since its FDA approval in 2002.
To treat aging-related issues, many patients seek treatment with cosmetic injectables. These products offer quick and convenient non-surgical revitalization and are quite popular.
DAXXIFY®
THE ONLY LONG-LASTING, PEPTIDE-POWERED FROWN LINE TREATMENT.
DAXXIFY® the only long-lasting*, peptide-powered, FDA-approved frown line treatment and the first innovation of its kind in over 20 years. Made in the United States. Created in innovative Silicon Valley, it continues to be manufactured there today.
*Conventional frown line treatments last 3-4 months. At least 50% of patients in clinical studies had no or minor frown lines 6 months after treatment with DAXXIFY®. In other safety studies, between 5% and 17% of patients still had noticeable improvement 9 months later
